OppenheimerFunds’s Loxo Oncology, Inc LOXO Stock Holding History

OppenheimerFunds’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,014,058	Closed	-$142M	–	1845
2018 Q4	$142M	Sell	1,014,058 -3,275	-0.3%	-$497K	0.2%	121
2018 Q3	$174M	Sell	1,017,333 -98,342	-9%	-$16.5M	0.2%	127
2018 Q2	$194M	Buy	1,115,675 +66,794	+6%	+$10M	0.23%	113
2018 Q1	$121M	Sell	1,048,881 -12,230	-1%	-$1.3M	0.15%	157
2017 Q4	$89.3M	Buy	1,061,111 +409,209	+63%	+$34.1M	0.11%	202
2017 Q3	$60.1M	Sell	651,902 -7,584	-1%	-$589K	0.07%	278
2017 Q2	$52.9M	Buy	+659,486	New	+$36.5M	0.07%	283

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $5.27B AUM 41.17% 1-Year Est. Return

OppenheimerFunds's LOXO Position: Q1 2019 in Review

OppenheimerFunds sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,014,058 shares — an estimated $142M sold.

OppenheimerFunds first reported a position in LOXO in Q2 2017 and held it in 7 quarters. The position peaked at $194M in Q2 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

OppenheimerFunds reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
OppenheimerFunds sold 1,014,058 Loxo Oncology, Inc shares in Q1 2019, an estimated $142M.
OppenheimerFunds first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 7 quarters.
OppenheimerFunds's Loxo Oncology, Inc position peaked at $194M in Q2 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.